CRA Life Sciences

0 Years of Experience

Articles from CRA Life Sciences:

Regulatory & Reimbursement

Overcoming the Funding Challenges of Bringing Digital Health Technologies to Market

There has been an increased focus on use of digital health technologies in recent years, now accelerated by the COVID-19 pandemic, but several barriers remain to market access, mainly regarding reimbursement. The Life Sciences Practice team at CRA explores these challenges and how companies might overcome them to encourage faster access and reimbursement of DHT. By Eva Marchese, Lev Gerlovin, Lorenzo D’Angelo, and Anthony Barron, CRA.

Read Article